Stock & Company Details
Agios Pharmaceuticals Inc $AGIO
Price:
46,691,331
59M
$2.2B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
1.70
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
AGIO technical indicators
Latest Agios Pharmaceuticals Inc (AGIO) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
72.41 8.4%
MACD:
2.36 1.4%
SMA 50:
$29.42 0.1%
SMA 200:
$31.73 0.0%
EMA 20:
$33.36 1.2%
Bollinger Bands:
39.76 / 24.34
Stochastic:
94.36 0.4%
ADX 14:
35.53 7.1%
ATR 14:
1.46 0.8%
CCI 20:
105.62 15.8%
OBV:
22.35M 4.2%
ROC 12:
29.21% 7.9%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
Finance Bot
Ask your questions
Start by typing a question below.
